Rates and predictors of adherence with atypical antipsychotic medication: A follow-up study of adolescent inpatients

Journal of Child and Adolescent Psychopharmacology

Volumn 15, Issue 6, 2005, Pages 901-912

  Pogge, David L ^a,b,d   Singer, Melissa Biren ^a   Harvey, Philip D ^c  

^a Four Winds Hospital   (United States)

^b FAIRLEIGH DICKINSON UNIVERSITY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Four Winds Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADOLESCENCE; ADOLESCENT; AKATHISIA; ANTICHOLINERGIC EFFECT; ARTICLE; BLURRED VISION; DEMOGRAPHY; DISEASE SEVERITY; DRUG EFFICACY; DRUG USE; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEMORY DISORDER; PATIENT COMPLIANCE; PSYCHOTHERAPY; RESTLESSNESS; SEDATION; SELF REPORT; SIDE EFFECT; SOMNOLENCE; SUBSTANCE ABUSE; SYMPTOMATOLOGY; WEIGHT GAIN; XEROSTOMIA;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FEMALE; HUMANS; MALE; MENTAL DISORDERS; PATIENT COMPLIANCE; PATIENT DISCHARGE; RISK FACTORS; RISPERIDONE; TREATMENT OUTCOME;

EID: 29944444486     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2005.15.901     Document Type: Article

References (36)

1. Adams J, Scott J: Predicting medication adherence in severe mental disorders. Acta Psychiatrica Scandinavica 101:119-124, 2000.
2. Adams SG, Howe JT: Predicting medication compliance in a psychotic population. J Nerv Ment Dis 181:553-560, 1993.
3. Bastiaens L: Compliance with pharmacotherapy in adolescents: Effects of patients' and parents' knowledge and attitudes toward treatment. J Child Adolesc Psychopharmacol 5:39-48, 1995.
4. Beardon PHG, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM: Primary noncompliance with prescribed medication in primary care. BMJ 307:846-848,1993.
5. Bernstein GA, Anderson LK, Hektner JM, Realmuto GM: Imipramine compliance in adolescents. JH Am Acad Child Adolesc Psychiatry 39:284-291, 2000.
6. Blackwell B: Compliance. Psychother Psychosom 58:161-169, 1992.
7. Buchanan A: A two-year prospective study of treatment compliance in patients with schizophrenia. Psychol Med 22:787-797, 1992.
8. Cromer BA, Tarnowski KJ: Noncompliance in adolescents: A review. Dev Behav Pediatr 10:207-215, 1989.
9. Davis JM, Chen N, Glick ID: A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry 60:553-564, 2003.
10. Derogatis LR: Hopkins Psychiatric Rating Scale. Baltimore, Clinical Psychometric Research, 1983.
11. Derogatis LR: Symptom Checklist-90-Revised. Towson, (MD), Clinical Psychometric Research, 1975.
12. Evans L, Spelman M: The problem of noncompliance with drug therapy. Drugs 25:63-76, 1983.
13. Friedman IM, Litt IF: Adolescents' compliance with therapeutic regimens: Psychological and social aspects and intervention. J Adolesc Health Care 8:52-67, 1987.
14. Gomez JC, Sacristan JA, Hernandez J, Brier A, Carrasco PR, Saiz CA, Carbonell EF: The safety of olanzapine compared with other antipsychotic drugs: Results of an observational prospective study in patients with schizophrenia (EFESO Study). J Clin Psychiatry 61:335-343, 2000.
15. Haywood TW, Kravits HM, Grossman LS, Cavanaugh JL, Davis JM, Lewis DA: Predicting the "Revolving Door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatry 152:856-861, 1995.
16. Jay S, DuRant RH, Litt IF: Reliability of riboflavin as an indicator of compliance with oral contraceptives. J Adolesc Health Care 3:140, 1982.
17. Jay S, DuRant RH, Litt IF, Shofitt T: Riboflavin, self-report, and serum norethindrone. Comparison of their use as indicators of adolescent compliance with oral contraceptives. Am J Dis Child 138:70-73, 1984.
18. Keck PE, McElroy SL, Strakowski SM, Balistreri TM, Kizer DL, West SA: Factors associated with maintenance antipsychotic treatment of patients with bipolar disorder. J Clin Psychiatry 57:147-151, 1996.
19. Lloyd A, Horan W, Borgaro SR, Stokes JM, Pogge DL, Harvey PD: Predictors of medication compliance after hospital discharge in adolescent psychiatric patients. J Child Adolesc Psychopharmacol 8:133-141, 1998.
20. Malone RP, Sheikh R, Zito JM: Novel antipsychotic medications in the treatment of children and adolescents. Psychiatric Serv 50:171-174, 1999.
21. Myers BA, Friedman S, Weiner IB: Coping with a chronic disability: Psychosocial observations of girls with scoliosis treated with the Milwaukee brace. Am J Dis Child 120:175-181, 1970.
22. Olfson M, Mechanic D, Hansell S, Boyer CA, Walkup J, Weiden PJ: Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr Serv 51:216-222, 2000.
23. Perkins DO: Adherence to antipsychotic medications. J Clin Psychiatry 60(Suppl 21):25-30, 1999.
24. Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Lieberman JA: Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 56:241-247, 1999.
25. Rudd P: The measurement of compliance: Medication taking. In Krasnegor NA, Epstein LH, Bennett Johnson S, Yaffe SJ (eds.) Developmental aspects of health compliance behavior Hillsdale (NJ): Lawrence Erlbaum Associates, 1993, pp 185-213.
26. Sclar DA, Tartaglione TA, Fine MJ: Overview of issues related to medical compliance with implications for the outpatient management of infectious diseases. Infect Agents Dis 3:266-273, 1994
27. Silva RR, Munoz DM, Daniel W, Barickman J, Friedhoff A: Causes of haloperidol discontinuation in patients with Tourette's Disorder: Management and alternatives. J Clin Psychiatry 57:129-135, 1996.
28. Stine JJ: Psychosocial and psychodynamic issues affecting noncompliance with psychostimulant treatment. J Child Adolesc Psychopharmacol 4:75-86, 1994.
29. Sullivan G, Wells KB, Morgenstern H, Leake B: Identifying modifiable risk factors for rehospitalization: A case-control study of seriously mentally ill persons in Mississippi. Am J Psychiatry 152:1749-1756, 1995.
30. Tebbi CK: Treatment compliance in childhood and adolescence. Cancer Supplement 71:3441-3449, 1993.
31. Tebbi CK, Cummings KM, Zevon MA, Smith L, Richards M, Mallon J: Compliance of pediatric and adolescent cancer patients. Cancer 58:1179-1184, 1986.
32. Warner LA, Silk K, Yeaton WH, Bargal D, Janssen J, Hill EM: Psychiatrists' and patients' views on drug information sources and medication compliance. Hosp Com Psychiatry 45:1235-1237, 1994.
33. Weiden PJ, Mackell JA, McDonnell DD: Obesity as a risk factor for antipsychotic noncompliance. Presented at the annual meeting of CINP, Brussels, Belgium, 2000.
34. Weiden PJ, Shaw E, Mann JJ: Causes of neuroleptic noncompliance. Psychiatr Ann 16:571-575, 1986.
35. Weiss RD, Greenfield SF, Najavits LM, Soto JA, Wyner D, Tohen M, Griffin ML: Medication compliance among patients with bipolar disorder and substance use disorder. J Clin Psychiatry 59:172-174, 1998.
36. Wirshing DA, Wirshing WC, Kysar L, Berisford MA, Goldstein D, Pashdag J, Mintz J, Marder SR: Novel antipsychotics: Comparison of weight gain liabilities. J Clin Psychiatry 60:358-363, 1999.